NCT00613808View on ClinicalTrials.gov

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

May 31, 2009

Conditions
Venous Ulcers
Interventions
DRUG

Nitric Oxide 200ppm Group B

200 ppm, 8hrs / day for 6 weeks

Trial Locations (2)

78211

Alamo Podiatry Associates, San Antonio

80220

Diabetic Foot & Wound Center, Denver

Sponsors
All Listed Sponsors
lead

Nitric BioTherapeutics, Inc

INDUSTRY

NCT00613808 - Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers | Biotech Hunter | Biotech Hunter